Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers discover unique approach to treat some chronic inflammatory diseases

Researchers discover unique approach to treat some chronic inflammatory diseases

Genetics may play a role in developing cancer therapy-induced cardiomyopathy

Genetics may play a role in developing cancer therapy-induced cardiomyopathy

Researchers map genetic mutation behind incurable disease

Researchers map genetic mutation behind incurable disease

Large-scale screen efficiently identifies drugs that are potent cancer-killers

Large-scale screen efficiently identifies drugs that are potent cancer-killers

‘Hit-and-run’ interaction between proteins appears to be key trigger for cell death

‘Hit-and-run’ interaction between proteins appears to be key trigger for cell death

Study compares library preparation and sequencing platforms for single-cell RNA-sequencing

Study compares library preparation and sequencing platforms for single-cell RNA-sequencing

Scientists visualize immune cells fighting blood cancer for the first time

Scientists visualize immune cells fighting blood cancer for the first time

Study finds no statistically significant effect of drug shortages on cancer treatment

Study finds no statistically significant effect of drug shortages on cancer treatment

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

Researchers discover how specific mutation obstructs healthy blood cell maturation

Researchers discover how specific mutation obstructs healthy blood cell maturation

On the border, volunteer doctors struggle to provide stopgap care to immigrants

On the border, volunteer doctors struggle to provide stopgap care to immigrants

New hope for treating devastating brain cancer in children

New hope for treating devastating brain cancer in children

Protein discovery opens door for new options in diagnosis and therapy of cancer

Protein discovery opens door for new options in diagnosis and therapy of cancer

Research reveals genomic basis of acute erythroid leukemia

Research reveals genomic basis of acute erythroid leukemia

Heating tumors during CAR T-cell therapy can enhance treatment's success, study suggests

Heating tumors during CAR T-cell therapy can enhance treatment's success, study suggests

Prostate cancer cells 'spit out' a protein that promotes tumor growth

Prostate cancer cells 'spit out' a protein that promotes tumor growth

Immune system errors linked to development of childhood leukemia

Immune system errors linked to development of childhood leukemia

Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia

Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

City of Hope receives $7.5 million in grant awards to study cutaneous T cell lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.